Entity family
Clinical therapies and care approaches used to manage a condition. Examples include immunotherapy, radiotherapy, rehabilitation.
Showing 2,821–2,880 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.
…Background Chimeric antigen receptor (CAR) T-cell therapy has transformed treatment for hematologic malignancies, but its…
…Background CAR T-cell therapy for prostate cancer presents several challenges, including poor…
…and/or eye), with limited treatment options upon relapse. While CD19-directed CAR-T cell therapies have revolutionized the treatment of systemic B-cell malignanci…
…euroendocrine skin cancer with limited treatment options. While chemo-immunotherapy remains the standard of care, nearly 50% of patients experience…
…Background CAR-T therapy has demonstrated curative potential against hematological malig…
…Background Chimeric antigen receptor (CAR) T cell therapy has demonstrated remarkable clinical efficacy in haematological…
…Background Chimeric Antigen Receptor T-cell (CAR-T) therapy has transformed treatments for hematologic malignancies, but ef…
… hematologic malignancies such as acute myeloid leukemia (AML). Intensive chemotherapy and prolonged neutropenia place these patients at high risk for…
…Background Chimeric antigen receptor (CAR) T-cell therapy, effective in certain hematologic malignancies, still has the p…
…Background Immune-based therapies have transformed cancer treatment; however, their effectiveness…
…ing the interaction between compromised DNA damage response and chemotherapy sensitivity.Conclusions In the myCare-040 cohort, most aberrati…